Press Releases

EASE FOR PATIENTS | LIST OF MEDICAL INSTITUTION PROVIDING AMEILE AND HANSOH XINFU AVAILABLE ON NHSA WEBSITE

STRIVE FOR HEALTHY CHINA!

WORLD INTELLECTUAL PROPERTY DAY | PROTECTING IP ASSETS, HANSOH PHARMA IS IN ACTION

EARTH DAY | PRACTICING GREEN DEVELOPMENT, HANSOH PHARMA ON THE WAY

EXPAND FIRST-LINE TREATMENT WITH COMBINED CHEMOTHERAPY – ANOTHER REGISTERED CLINICAL STUDY OF ALMONERTINIB WAS APPROVED

GOLD SHINES BRIGHTER AFTER COMING OUT FROM FIRE丨HANSOH XINFU'S REAL-WORLD CLINICAL EFFECT IS HIGHLY RECOGNIZED

CLINICAL RECRUITMENT | SUBJECT RECRUITMENT FOR USE OF ALMONERTINIB IN TREATMENT OF NON-PROGRESSIVE NSCLC AFTER RADICAL PLATINUM-CONTAINING CHEMORADIOTHERAPY

CLINICAL RECRUITMENT | SUBJECT RECRUITMENT FOR USE OF ALMONERTINIB IN POSTOPERATIVE ADJUVANT THERAPY OF NSCLC